Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 942

1.
2.

[Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].

Merlino C, Giacchino F, Bergallo M, Bonello F, Bollero C, Segoloni GP, Cavallo R.

G Ital Nefrol. 2003 Mar-Apr;20(2):170-5. Italian.

PMID:
12746803
4.

Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.

Meerbach A, Wutzler P, Häfer R, Zintl F, Gruhn B.

J Med Virol. 2008 Mar;80(3):441-54. doi: 10.1002/jmv.21096.

PMID:
18205222
5.

Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.

Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.

J Heart Lung Transplant. 2008 Jan;27(1):100-5. doi: 10.1016/j.healun.2007.09.027.

PMID:
18187094
7.

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.

Omar H, Hägglund H, Gustafsson-Jernberg A, LeBlanc K, Mattsson J, Remberger M, Ringdén O, Sparrelid E, Sundin M, Winiarski J, Yun Z, Ljungman P.

Transpl Infect Dis. 2009 Oct;11(5):393-9. doi: 10.1111/j.1399-3062.2009.00410.x. Epub 2009 May 26.

PMID:
19497070
8.

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients.

Stevens SJ, Verschuuren EA, Pronk I, van Der Bij W, Harmsen MC, The TH, Meijer CJ, van Den Brule AJ, Middeldorp JM.

Blood. 2001 Mar 1;97(5):1165-71.

9.

Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.

Lee TC, Savoldo B, Barshes NR, Rooney CM, Heslop HE, Gee AP, Caldwell Y, Scott JD, Goss JA.

Clin Transplant. 2006 May-Jun;20(3):389-93.

PMID:
16824159
11.
12.

The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.

Kogan-Liberman D, Burroughs M, Emre S, Moscona A, Shneider BL.

J Pediatr Gastroenterol Nutr. 2001 Oct;33(4):445-9.

PMID:
11698761
13.

Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.

Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dörken B, Riess H, Gärtner B.

Ann Hematol. 2006 Jul;85(7):478-84. Epub 2006 Apr 4.

PMID:
16586109
14.

Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease.

Green M, Cacciarelli TV, Mazariegos GV, Sigurdsson L, Qu L, Rowe DT, Reyes J.

Transplantation. 1998 Dec 27;66(12):1641-4.

PMID:
9884252
15.
16.

Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.

Merlino C, Cavallo R, Bergallo M, Giacchino F, Bollero C, Negro Ponzi A, Cavallo G.

New Microbiol. 2003 Apr;26(2):141-9.

PMID:
12737195
17.
18.

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation.

van Esser JW, Niesters HG, van der Holt B, Meijer E, Osterhaus AD, Gratama JW, Verdonck LF, Löwenberg B, Cornelissen JJ.

Blood. 2002 Jun 15;99(12):4364-9.

19.

Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD.

Sebelin-Wulf K, Nguyen TD, Oertel S, Papp-Vary M, Trappe RU, Schulzki A, Pezzutto A, Riess H, Subklewe M.

Transpl Immunol. 2007 Apr;17(3):203-10. Epub 2006 Nov 29.

PMID:
17331848
20.

Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation.

Coppoletta S, Tedone E, Galano B, Soracco M, Raiola AM, Lamparelli T, Gualandi F, Bregante S, Ibatici A, di Grazia C, Dominietto A, Varaldo R, Bruno B, Frassoni F, Van Lint MT, Bacigalupo A.

Biol Blood Marrow Transplant. 2011 Jun;17(6):901-7. doi: 10.1016/j.bbmt.2010.10.003. Epub 2010 Oct 13.

Items per page

Supplemental Content

Write to the Help Desk